About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Objective Assessment of Adherence to Inhalers by COPD Patients

NCT04025242·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Beaumont Hospital

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients hospitalised with an exacerbation of COPD
FEV1/FVC \<70% or FEV1 \<80%
Age\>40 years
smoking history
Previously prescribed fluticasone/salmeterol inhaler

You may not be if

No exacerbations in previous year
Outpatients

The record

StatusCompleted

PhaseNo phase

Taking part244

StartedFeb 2012

UpdatedJul 23, 2019

Conditions

Clareo Health | Objective Assessment of Adherence to Inhalers by COPD Patients